Very Low Incidence of Arg506 → Gin Mutation in the Factor V Gene among the Amazonian Indians and the Brazilian Black Population

• References

• 1 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U.S.A 1993; 90: 1004-1008
• 2 Koster T, Rosendaal FR, de Ronde H, Brièt E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
• 3 Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in the majority of thrombophilic patients. Blood 1993; 82: 1989-1993
• 4 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
• 5 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 6 Dalhbäck B. Resistance to activated protein C, the Arg506 to Gin mutation in the factor V gene, and venous thrombosis. Thromb Haemost 1995; 73: 739-742
• 7 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
• 8 Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-917
• 9 Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activate protein C resistance). Blood 1995; 85: 1504-1508
• 10 Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457
• 11 Majeurs PW. Bad blood by mutation. Nature 1994; 369: 14-15
• 12 Arruda VR, Annichino-Bizzacchi JM, Costa FF, Reitsma PH. Factor V Leiden (FVQ506) is common in Brazilian population. Am J Hematol 1995; 39: 242-243
• 13 Curtin PD. The Slave Atlantic Trade: A Census. University of Winconsin Press; Milwaukee: 1969
• 14 Ferrer-Antunes C, Palmeiro A, Green F, Rosa H, Feliciano B, Silva E. Polymorphisms of fibrinogen, factor VII and factor V genes comparison of allele frequencies in different ethnic groups. Thromb Haemost 1995; 73: 1379
• 15 Dilley A, Austin H, Cupertino M, Hooper C, Wenger N, Evatt B. Risk factors for deep vein thrombosis in an African-American population. Blood 1995; 86: 87 a
• 16 Cavalli-Sforza LL, Piazza A, Menozzi P, Montain J. Reconstruction of human evolution: bringing together genetic, archaeological and linguistic data. Proc Natl Acad Sci USA 1988; 85: 6002-6006
• 17 Black FL, Salzano FM, Layrisse Z, Franco MHLP, Harris NS, Weimer TA. Restriction and persistence of polymorphisms of HLA and other blood genetic traits in the Parakana Indians of Brazil. Am J Phys Anthr 1980; 52: 119-132
• 18 Takamiya O, Ishida F, Kodaira H, Kitano K. APC-resistance and Mnll genotype (Gin 506) of coagulation factor V are rare in Japanese population. Thromb Haemost 1995; 74: 996
• 19 Pattison JK, Millar DS, McVey JH, Grundy CB, Wieland K, Mibashan RS, Martinowitz U, Tan-Un K, Vidaud M, Goossens M, Sampietro M, Mannucci PM, Krawczak M, Reiss T, Zoll B, Whitmore D, Bowcock S, Wensley R, Ajani A, Mitchell V, Rizza C, Maia R, Winter P, Mayne EE, Schwartz M, Green PJ, Kakkar VV, Tuddenham EGD, Cooper DN. The molecular genetic analysis of hemophilia A: a directed search strategy for the detection of point mutations in the human factor VIII gene. Blood 1990; 76: 2242-2248
• 20 Behn-Krappa A, Holner I, Sandaradura de SilvaU, Doerfler W. Patterns of DNA methylation are indistinguishable in different individuals over a wide range of human DNA. Genomics 1991; 11: 1-7